Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach
about
The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohortWhat is the true number needed to screen and treat to save a life with prostate-specific antigen testing?Evidence for field cancerization of the prostate.An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate interventionProstate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyDevelopment and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience.Toward the detection of prostate cancer in urine: a critical analysis.Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Addressing the need for repeat prostate biopsy: new technology and approaches.The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla.Greater extent of prostate inflammation in negative biopsies is associated with lower risk of prostate cancer on repeat biopsy: results from the REDUCE study.Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection.A role of human beta defensin-1 in predicting prostatic adenocarcinoma in cases of false-negative biopsy.Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE study.Utility of single cell genomics in diagnostic evaluation of prostate cancer.Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.PSA enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness.Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.
P2860
Q33980987-8F9246B0-81CF-4235-89C2-88A6AEA7159BQ34679360-B9944427-FECE-49EB-8763-D27294A9C219Q34982560-DC9FB715-2541-4232-B7A4-0C27DAD08217Q35821982-C6515D73-1DCF-45DC-9754-DCCA13BBE510Q36142278-FF9E725D-BCC1-400F-BECD-AA25D030C66DQ36529675-4ADB55F8-4899-464C-8A7E-CCCB582943A2Q37892629-EA93A358-30C2-4718-A454-C8723859B381Q38047103-9E0B03F4-51D5-4C0D-88BA-17D5D317A800Q38170026-11E28D70-88CF-466A-BBA6-61E8BEB88566Q38211603-468EE173-1F0A-4F67-8519-89ECEBC7B6F1Q38546671-90BF8BA9-8AC2-4023-8281-2BA549A87F56Q38825859-F75EDF13-7A7B-42AE-AD9B-672D41E11F0AQ39439451-9BD79496-7927-4A29-B852-0E902EBEB97EQ40967154-F6C427CA-328E-418D-85EB-CE7ABC98D62BQ42413527-9A1D34E1-BE7D-408D-A031-A463700127E4Q42514699-AE23BE61-6202-4D61-8477-C1A0F75BF503Q42558314-10219EBA-12E8-4A6B-B67D-C9BF360E2698Q43431647-F351E1AC-07C8-44E8-98A7-880A92C84FB1Q44130971-4FCDB903-AB9E-4353-99CE-203961914749Q46518241-B26C42BB-2339-4091-B57C-0F41ABBD7783Q47303003-58848EDF-80AB-4D6D-9F61-88D5F53488A4Q47624531-48CEBD8E-4CD3-42F0-BA89-94D06D036B2FQ47646760-D5A11F05-AD60-49BD-A6E4-D77F12840632
P2860
Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Risk factors for prostate canc ...... variable longitudinal approach
@ast
Risk factors for prostate canc ...... variable longitudinal approach
@en
type
label
Risk factors for prostate canc ...... variable longitudinal approach
@ast
Risk factors for prostate canc ...... variable longitudinal approach
@en
prefLabel
Risk factors for prostate canc ...... variable longitudinal approach
@ast
Risk factors for prostate canc ...... variable longitudinal approach
@en
P2093
P2860
P356
P1476
Risk factors for prostate canc ...... variable longitudinal approach
@en
P2093
Angela Fought
Edward Vonesh
Peter H Gann
Ryan Deaton
William J Catalona
P2860
P304
P356
10.1200/JCO.2008.20.3422
P407
P577
2010-02-22T00:00:00Z